Date Published
Country
Source
Videos
close
-
Are Drug Prices Too High? Should QALYs Be Used to Measure a Drug's Value? And Should a Government Entity Be Making Price and Value Determinations? A Conversation with Dan Ollendorf.
Dan Ollendorf, Ph.D., M.P.H.,of the Center for the Evaluation of Value and Risk in Health at Tufts University Medical Center, is co-author of a new book, The Right Price, A Value-Based Prescription for Drug Costs. -
Steven D. Pearson Shares if PCSK9 Pricing Put ICER on Map
Steven D. Pearson, M.D., M.Sc., founder and president of ICER addresses if pricing of PCSK9 inhibitors put ICER on the map.Comments
-
Stephen Pearson of ICER Talks Access and Price of Cholesterol Agents
Can price affect access?
Comments
-
Are Ultra-High Drug Prices Sustainable?
Discussion on high-priced drugs and whether the prices are sustainable in the long run.Comments
-
Ahead of G7, Macron Urges US and Europe to Allocate Vaccines to Poor Nations
French President Emmanuel Macron called on Thursday for the US and European nations to allocate up to 5% of current vaccine supplies to developing countries.Comments
Comments